AstrazenecaAZN
13F holders, Q2 2025 (June 30)5holders +1
1new positions
0sold out
$137.56avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Boston Common Asset Management, LLC ($25.3M), FNY Investment Advisers, LLC ($2.0M) and SWP Investment Management LLC ($1.8M).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $425K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 6,309 shares bought and 3,557 shares sold, net +2,752 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Boston Common Asset Management, LLC | 0.71% | Reduce -1.9% | 182,435 | $25.3M |
| FNY Investment Advisers, LLC | 0.88% | No change | 200 | $2.0M |
| SWP Investment Management LLC | 2.15% | Add +0.9% | 26,055 | $1.8M |
| Old Mission Capital LLC | 0.01% | New | 6,078 | $425K |
| Raffa Wealth Management, LLC | 0.01% | Reduce -14.1% | 379 | $26K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.